Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (69)

1

Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir : data from the ICONA Cohort

enthalten in: HIV clinical trials | 2018

von d'Arminio Monforte, A. | Lorenzini, P. | Cozzi-Lepri, A. | +10

2

Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals

enthalten in: HIV clinical trials | 2018

von Jackson, A. | Else, L. | Higgs, C. | +6

3

HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen

enthalten in: HIV clinical trials | 2017

von Karris, M. | Jain, S. | Day, T. | +9

4

Efficacy and safety of "unboosting" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DF

enthalten in: HIV clinical trials | 2017

von Harris, M. | Ganase, B. | Watson, B. | +5

5

Cobicistat-boosted protease inhibitors in HIV-infected patients with mild to moderate renal impairment

enthalten in: HIV clinical trials | 2014

von McDonald, C. | Martorell, C. | Ramgopal, M. | +10

6

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection : data from the ICONA foundation cohort

enthalten in: HIV clinical trials | 2014

von Di Biagio, A. | Nicolini, L. | Lorenzini, P. | +10

7

Is there a higher risk of CNS adverse events for PI monotherapy versus triple therapy? A review of results from randomized clinical trials

enthalten in: HIV clinical trials | 2014

von Powderly, W. | Hill, A. | Moecklinghoff, C.

8

Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART

enthalten in: HIV clinical trials | 2013

von Casado, J. | de Los Santos, I. | Del Palacio, M. | +4

9

Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial

enthalten in: HIV clinical trials | 2013

von Geretti, A. | Arribas, J. | Lathouwers, E. | +6

10

Meta-analysis of the safety, tolerability, and efficacy of lopinavir/ritonavir-containing antiretroviral therapy in HIV-1-infected women

enthalten in: HIV clinical trials | 2012

von Hermes, A. | Squires, K. | Fredrick, L. | +4

1
2
3
4
5
6
7
Nächster »
[7]